SHARE
COPY LINK

COVID-19 VACCINES

Covid-19: Denmark expects to bring updated jab into vaccination programme

An updated version of Pfizer’s Covid-19 vaccine, tabled by the European Medical Agency (EMA) for EU approval, is likely to be used in Denmark.

Covid-19: Denmark expects to bring updated jab into vaccination programme
Denmark is expected to integrate an updated version of the Pfizer Covid-19 vaccine into its national booster programme. File photo: Mads Claus Rasmussen/Ritzau Scanpix

The Danish Health Authority said that it expects the vaccine, which has been updated to protect against the currently dominant variant of the coronavirus, will be used in the autumn vaccination programme.

“We now have several variant-updated vaccines which we expect to give both better and broader protection against serious illness and death,” the deputy director of the Danish Health Auhtority, Helene Bilsted Probst, said in a press statement.

“We expect that the updated vaccine will give at least as good protection as the already-approved BA1-updated vaccine, and it could possibly be a little better,” she said.

The Health Authority is expected to make a decision in the near future on how doses of the latest update will be integrated into the existing vaccine programme.

Denmark’s autumn Covid-19 vaccination programme is scheduled to begin on September 15th, when care home residents and people aged 85 and over will be invited for a booster vaccine.

From October 1st, everyone aged 50 and over will be offered vaccination.

“Everyone who will be vaccinated in the autumn vaccination programme will be vaccinated with the variant-updated vaccine, and we will continuously assess how best to use it,” Probst said in the statement.

Other groups for which vaccination is recommended include those who are pregnant, work in the health and elderly care sectors, or are at heightened risk of serious illness.

Denmark took delivery of 720,000 Pfizer vaccines late last week and has secured a total of 4.5 million doses that will be delivered this month.

Probst stated that timely vaccination was important in reducing the likelihood of serious illness.

“So we need to get started so we can keep ahead of the virus,” she said.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19 VACCINES

EU approves new dual-strain Covid vaccines in time for autumn booster campaigns

The European Medicines Agency has approved two new Covid vaccines that are designed to protect against both the original strain of the virus and the new Omicron variants.

EU approves new dual-strain Covid vaccines in time for autumn booster campaigns

Both Pfizer and Moderna had submitted applications for their dual-strain vaccines to the European Medicines Agency (EMA) in mid-July, with the agency announcing on Thursday that both had been approved.

The vaccines target both the Omicron variant and the original strain of Covid, but do not specifically target the Omicron BA.4 and BA.5 sub-variants that have emerged as the global dominant strains in recent months.

The EMA approval comes after the US approved both vaccines on Wednesday, while the UK approved the Moderna dual-strain vaccine in mid-August.

Within the EU, countries have the choice of accepting the EMA recommendation straight out, or asking their own domestic health regulator to give its approval.

The dual-strain vaccines are widely expected to be used in Covid booster shot campaigns this autumn, which many countries plan to combine with the annual flu vaccination drive. 

SHOW COMMENTS